The Copenhagen company says its Symphony model has outscored OpenAI on HealthBench Professional, and is offering credits and regulatory help to founders building healthcare AI worldwide. Corti, the Copenhagen-based clinical AI company, has launched a n…
Bristol Myers Squibb has signed a deal worth up to 15.2 billion dollars with Jiangsu Hengrui Medicine, China’s largest pharmaceutical company by market capitalisation. The agreement covers 13 early-stage drug programmes across oncology, haematology, …
Ditto, an Amsterdam-based health-tech building AI-generated summaries of medical appointments for patients, has raised €7.6m, the company said on Monday. The round is led by Heal Capital with participation from Rubio Impact Ventures. Earlier backer Chr…
Novo will take an equity stake in Cellular Intelligence and is in line for future milestone payments and royalties. The startup plans to apply its AI platform to STEM-PD, a stem-cell-derived treatment Novo discontinued last October. Novo Nordisk has ha…
A state investigator in Pennsylvania created an account on Character.AI, opened a conversation with a chatbot called Emilie, and told it he was feeling depressed. Emilie responded that she was a psychiatrist, that she had attended Imperial College Lond…
The pitch deck version of digital health goes something like this: AI replaces the clinician, costs drop, access expands, outcomes improve, everyone wins. The pitch has been effective. Venture capital has poured billions into companies built around the…
The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseases are treated. Candid Therapeutics is two years old…
The company that built TikTok’s recommendation algorithm, the system that predicts with unsettling accuracy what a person wants to watch next, is now using a related class of AI to predict how molecules will behave inside a human body. ByteDance’s drug…
Most of the umbilical cord blood collected at birth is discarded. The tissue is clamped, cut, and disposed of as medical waste, along with the stem cells it contains, cells that are immunologically naive, genetically diverse, and capable of being repro…
The Munich techbio company is developing a live bacterial product designed to enhance immune checkpoint inhibitor response in advanced melanoma, with a Phase 1B study planned for 2027 mbiomics GmbH, a Munich-based techbio company developing microbiome-…